Results 231 to 240 of about 115,987 (377)
Proteinuria induced by anti-dipeptidyl peptidase IV (gp108); role of circulating and glomerular antigen [PDF]
Y Natori, Noboru Shindo, Y Natori
openalex +1 more source
Sita‐ and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross‐sectional study
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Sören Dräger +8 more
wiley +1 more source
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman +13 more
wiley +1 more source
ABSTRACT Background Previous studies reported an inverse association between diabetes and prostate cancer. Moreover, the associations of smoking with breast and prostate cancers remain inconclusive. This study aims to investigate whether diabetes, smoking, or metabolic factors are associated with female breast and prostate cancers incidence, and ...
Sarah Tsz Yui Yau +4 more
wiley +1 more source
Elevated circulating dipeptidyl peptidase 3 (cDPP3) as a predictor of postoperative complications in esophagectomy patients. [PDF]
Nottberg VI +9 more
europepmc +1 more source
Glucagon-like Peptide-1 Analogue and Dipeptidyl Peptidase-IV Inhibitors [PDF]
Seungjoon Oh
openalex +1 more source
Vildagliptin and omarigliptin, dipeptidyl peptidase‐4 (DPP‐4) inhibitors, have differential effects on bone cells. Although vildagliptin improved the bone microstructure of high‐fat diet‐fed rats, it was unable to downregulate osteoclastogenesis or the expression of key osteoclast transcripts.
Ratchaneevan Aeimlapa +11 more
wiley +1 more source
Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. [PDF]
Mai S +6 more
europepmc +1 more source

